{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:04:11Z","timestamp":1790935451272,"version":"4.1.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Raloxifene is a selective estrogen receptor modulator that has been shown to increase bone density. The purpose of this study was to examine the effects of raloxifene on bone tissue by studying bone biopsy specimens before and after 2 years of raloxifene or placebo therapy. The women in this study were participants of the double-blind, placebo-controlled, multicenter study, the Multiple Outcomes of Raloxifene Evaluation (MORE) trial. Subjects from two U.S. sites and two European sites were included if they consented to a bone biopsy. Iliac crest bone biopsies were performed at baseline and after 2 years. Tetracycline labeling preceded each biopsy. A total of 65 paired biopsy specimens were evaluated with 25, 22, and 18 patients in the placebo, raloxifene HCl (60 mg) and raloxifene HCl (120 mg) treatment groups, respectively. They were analyzed using standard histomorphometry. None of the biopsy specimens showed evidence of toxic effects on bone or bone cells or met criteria for osteomalacia. Biopsy specimens in the placebo and raloxifene groups had the appearance of normal bone, with no evidence of marrow fibrosis or increases in the amount of woven bone or numbers of empty osteocyte lacunae. Compared with the baseline, the bone formation rate (BFR) decreased significantly in both raloxifene groups. The change in BFR in the group treated with 120 mg of raloxifene was \u221262.3%, which was significantly lower than the change in the placebo group of \u221221.0% (p = 0.03). No change in resorption parameters could be measured by histomorphometry, but there was a decrease in urinary type I collagen excretion. The results from this study suggest that raloxifene has actions on bone tissue that are similar to those observed with estrogen. The depressive effects on bone remodeling are less marked than the effects seen with alendronate.<\/jats:p>","DOI":"10.1359\/jbmr.2002.17.2.341","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T04:16:38Z","timestamp":1146111398000},"page":"341-348","source":"Crossref","is-referenced-by-count":95,"title":["Bone Histomorphometric and Biochemical Marker Results of a 2-Year Placebo-Controlled Trial of Raloxifene in Postmenopausal Women"],"prefix":"10.1093","volume":"17","author":[{"given":"Susan M.","family":"Ott","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Oleksik","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yili","family":"Lu","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Indianapolis, Indiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Harper","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Indianapolis, Indiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lips","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,2]]},"reference":[{"key":"2024013107471898600_bib1","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199712043372301","article-title":"Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women","volume":"337","author":"Delmas","year":"1997","journal-title":"N Engl J Med"},{"key":"2024013107471898600_bib2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"2024013107471898600_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s001980050236","article-title":"Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study Group","volume":"10","author":"Meunier","year":"1999","journal-title":"Osteoporos Int"},{"key":"2024013107471898600_bib4","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1359\/jbmr.1998.13.11.1747","article-title":"Treatment of established postmenopausal osteoporosis with raloxifene: A randomized trial","volume":"13","author":"Lufkin","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2024013107471898600_bib5","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effect of raloxifene on risk of breast cancer in postmenopausal women: Results from the MORE randomized trial. Multiple outcomes of raloxifene evaluation","volume":"281","author":"Cummings","year":"1999","journal-title":"JAMA"},{"key":"2024013107471898600_bib6","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1359\/jbmr.2000.15.7.1368","article-title":"Bone structure in patients with low bone mineral density with or without vertebral fractures","volume":"15","author":"Oleksik","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2024013107471898600_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0221-8747(82)90024-8","article-title":"Estimation of the three-dimensional wall thickness of completed remodeling sites in iliac trabecular bone","volume":"4","author":"Kragstrup","year":"1982","journal-title":"Metab Bone Dis Relat Res"},{"key":"2024013107471898600_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF02556831","article-title":"Inter-observer and intra-observer variation in bone histomorphometry","volume":"38","author":"Compston","year":"1986","journal-title":"Calcif Tissue Int"},{"key":"2024013107471898600_bib9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: Standardization of nomenclature, symbols, and units","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"key":"2024013107471898600_bib10","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1214\/aos\/1176345462","article-title":"The jackknife estimate of variance","volume":"9","author":"Efron","year":"1981","journal-title":"Ann Stat"},{"key":"2024013107471898600_bib11","first-page":"329","volume-title":"Metabolic Bone Disease","author":"Parfitt","year":"1990"},{"key":"2024013107471898600_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s001980050175","article-title":"Bone histomorphometric evaluation of pamidronate treatment in clinically manifest osteoporosis","volume":"9","author":"Bravenboer","year":"1999","journal-title":"Osteoporos Int"},{"key":"2024013107471898600_bib13","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1172\/JCI119668","article-title":"Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis","volume":"100","author":"Chavassieux","year":"1997","journal-title":"J Clin Invest"},{"key":"2024013107471898600_bib14","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/jbmr.5650110615","article-title":"A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal women","volume":"11","author":"Draper","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2024013107471898600_bib15","first-page":"2197","article-title":"A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women","volume":"85","author":"Prestwood","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013107471898600_bib16","first-page":"3425","article-title":"Raloxifene and estrogen: Comparative bone-remodeling kinetics","volume":"82","author":"Heaney","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013107471898600_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S8756-3282(97)00275-5","article-title":"Effect of estrogen suppression on the mineralization density of iliac crest biopsies in young women as assessed by backscattered electron imaging","volume":"22","author":"Boyde","year":"1998","journal-title":"Bone"},{"key":"2024013107471898600_bib18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S8756-3282(00)00376-8","article-title":"Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women","volume":"27","author":"Boivin","year":"2000","journal-title":"Bone"},{"key":"2024013107471898600_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/8756-3282(89)90126-9","article-title":"A randomized study on the effects of estrogen\/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis","volume":"10","author":"Steiniche","year":"1989","journal-title":"Bone"},{"key":"2024013107471898600_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S8756-3282(98)00177-X","article-title":"Early effects of hormone replacement therapy on bone","volume":"24","author":"Patel","year":"1999","journal-title":"Bone"},{"key":"2024013107471898600_bib21","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1359\/jbmr.1999.14.7.1217","article-title":"Hormone replacement therapy prevents osteoclastic hyperactivity: A histomorphometric study in early postmenopausal women","volume":"14","author":"Eriksen","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2024013107471898600_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-117-1-1","article-title":"Treatment of postmenopausal osteoporosis with transdermal estrogen","volume":"117","author":"Lufkin","year":"1992","journal-title":"Ann Intern Med"},{"key":"2024013107471898600_bib23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S8756-3282(96)00227-X","article-title":"The effects of long-term hormone replacement therapy on bone remodeling in postmenopausal women","volume":"19","author":"Vedi","year":"1996","journal-title":"Bone"},{"key":"2024013107471898600_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s001980050194","article-title":"Bone remodeling and structure in postmenopausal women treated with long-term, high-dose estrogen therapy","volume":"10","author":"Vedi","year":"1999","journal-title":"Osteoporos Int"},{"key":"2024013107471898600_bib25","first-page":"387","article-title":"Histomorphometric changes in the skeleton of postmenopausal women with low bone mineral density treated with percutaneous estradiol implants","volume":"83","author":"Holland","year":"1994","journal-title":"Obstet Gynecol"},{"key":"2024013107471898600_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/jbmr.5650090204","article-title":"Effect of long-term tamoxifen therapy on cancellous bone remodeling and structure in women with breast cancer","volume":"9","author":"Wright","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2024013107471898600_bib27","first-page":"968","article-title":"Bone histomorphometric changes following cyclic therapy with phosphate and etidronate disodium in women with postmenopausal osteoporosis","volume":"78","author":"Ott","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013107471898600_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/jbmr.5650080211","article-title":"Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis","volume":"8","author":"Storm","year":"1993","journal-title":"J Bone Miner Res"},{"key":"2024013107471898600_bib29","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1359\/jbmr.2000.15.4.754","article-title":"Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: A histomorphometric analysis of transiliac biopsies","volume":"15","author":"Chavassieux","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2024013107471898600_bib30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","article-title":"Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib","volume":"15","author":"Mashiba","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2024013107471898600_bib31","first-page":"369","article-title":"Histomorphometric analysis of normal bone from the iliac crest of Norwegian subjects","volume":"3","author":"Dahl","year":"1988","journal-title":"Bone Miner"},{"key":"2024013107471898600_bib32","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1210\/jcem-67-4-741","article-title":"Bone formation rate in older normal women: Concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers","volume":"67","author":"Eastell","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013107471898600_bib33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0221-8747(83)90004-8","article-title":"Histomorphometric analysis of dynamic parameters of trabecular bone formation in the iliac crest of normal British subjects","volume":"5","author":"Vedi","year":"1983","journal-title":"Metab Bone Dis Relat Res"},{"key":"2024013107471898600_bib34","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1359\/jbmr.1997.12.11.1864","article-title":"Effects of ethnicity and age or menopause on osteoblast function, bone mineralization, and osteoid accumulation in iliac bone","volume":"12","author":"Parfitt","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2024013107471898600_bib35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/8756-3282(85)90003-1","article-title":"Metabolic bone disease with and without osteomalacia after intestinal bypass surgery: A bone histomorphometric study","volume":"6","author":"Parfitt","year":"1985","journal-title":"Bone"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.2002.17.2.341","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/17\/2\/341\/56472057\/5650170218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/17\/2\/341\/56472057\/5650170218.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:04:32Z","timestamp":1710342272000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/17\/2\/341-348\/7585806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2,1]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,12,2]]},"published-print":{"date-parts":[[2002,2,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.2002.17.2.341","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2002,2,1]]},"published":{"date-parts":[[2002,2,1]]}}}